reports
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-...
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List Attributes 234% Revenue Growth to Operational Excellence and Strong Commercial Execution CORAL GABLES, Fla., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), today announced it ranked number 452 on the ™, a ranking of the 500 fastest-growing technology media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 30th year. The 2024 Deloitte Technology F...
- Jonathan Moreland
RMAX RE/MAX HOLDINGS INC.
PSEC PROSPECT CAPITAL CORPORATION
PPSI PIONEER POWER SOLUTIONS
PBF PBF ENERGY INC. CLASS A
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MPAA MOTORCAR PARTS OF AMERICA INC.
GLP GLOBAL PARTNERS LP
EL ESTEE LAUDER COMPANIES INC. CLASS A
APPS DIGITAL TURBINE
ACRS ACLARIS THERAPEUTICS INC.
MEDP MEDPACE HOLDINGS INC.
ENPH ENPHASE ENERGY INC.
HTLD HEARTLAND EXPRESS INC.
RAIL FREIGHTCAR AMERICA INC.
SVRA SAVARA
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
ANGI ANGI INC. CLASS A
SNBR SLEEP NUMBER CORPORATION
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
MBIN MERCHANTS BANCORP
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
NOVA SUNNOVA ENERGY INTERNATIONAL
GRWG GROWGENERATION
PCB PACIFIC CITY FINANCIAL CORP
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
ONEW ONEWATER MARINE
BDSX BIODESIX
CSU CAPITAL SENIOR LIVING
MODV MODIVCARE INC
GRNT GRANIT SKOPKE
UAN CVR PARTNERS LP
INBX INHIBRX
OSCR INC.
WOLF OSCAR HEALTH
CLVT WOLFSPEED INC
ZETA CLARIVATE PLC
RWAY ZETA GLOBAL HLDGS CORP
CGBD RUNWAY GROWTH FINANCE CORP
NXGL TCG BDC
BIGZ INC.
DOUG NEXGEL INC
KLG_w BLACKROCK INNOVATION AND GROWTH TST
EP DOUGLAS ELLIMAN INC
MIO WK KELLOGG CO
MDRR EMPIRE PETROLEUM CORP
BNTC PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
EVM MEDALIST DIVERSIFIED REIT INC.
FGF BENITEC BIOPHARMA INC
EATON VANCE INSD CALIF MUN BD FD
FG FINANCIAL GROUP
INC.
- Jonathan Moreland
PBF PBF ENERGY INC. CLASS A
MEDP MEDPACE HOLDINGS INC.
SACH SACHEM CAPITAL
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
NOVA SUNNOVA ENERGY INTERNATIONAL
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
ONEW ONEWATER MARINE
BDSX BIODESIX
MODV MODIVCARE INC
UAN CVR PARTNERS LP
WOLF WOLFSPEED INC
BIGZ BLACKROCK INNOVATION AND GROWTH TST
GRNT GRANITE RIDGE RESOURCES INC
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
BNTC BENITEC BIOPHARMA INC
EVM EATON VANCE INSD CALIF MUN BD FD
FGF FG FINANCIAL GROUP
INC.
Lesaka to acquire prepaid electricity submetering and payments busines...
Lesaka to acquire prepaid electricity submetering and payments business Recharger, expanding alternative payments offering JOHANNESBURG, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) (“Lesaka” or the “Company”) today announced that it has signed a definitive agreement to acquire 100% of the issued and outstanding ordinary shares of Recharger (Pty) Ltd (“Recharger”), a South African prepaid electricity submetering and payments business. The purchase consideration of ZAR 507 million ($28 million translated at the average exchange rate of $1: ZAR 18.06...
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferenc...
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences CORAL GABLES, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate in the upcoming investor conferences detailed below. Piper Sandler 36th...
- Jonathan Moreland
SEDG SOLAREDGE TECHNOLOGIES INC.
SATS ECHOSTAR CORPORATION CLASS A
PBF PBF ENERGY INC. CLASS A
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MCHX MARCHEX INC. CL B
KVHI KVH INDUSTRIES INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
HSII HEIDRICK & STRUGGLES INTERNATIONAL INC.
HASI
I3N HANNON ARMSTRONG SUSTAINABLE INFRASTRUCTURE CAPITAL INC.
GDOT CHART INDUSTRIES INC.
EXAS GREEN DOT CORPORATION CLASS A
CROX EXACT SCIENCES CORPORATION
CNC CROCS INC.
AGCO CENTENE CORPORATION
AVNW AGCO CORPORATION
ENPH AVIAT NETWORKS
HTLD ENPHASE ENERGY INC.
ZOM HEARTLAND EXPRESS INC.
DMLP ZOMEDICA PHARMACEUTICALS CORP
MAV DORCHESTER MINERALS L.P.
HLNE PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
SNBR HAMILTON LANE INCORPORATED CLASS A
MHI SLEEP NUMBER CORPORATION
GNL PIONEER MUNICIPAL HIGH INCOME TRUST
BBDC GALEY & LORD INC.
CLDX BARINGS BDC INC.
ENX CELLDEX THERAPEUTICS INC.
ADV EATON VANCE NEW YORK MUNICIPAL BOND FUND
HPK ADVANTAGE SOLUTIONS INC (A)
MRVI HIGHPEAK ENERGY INC (A)
OPCH MARAVAI LIFESCIENCES HOLDINGS
MODV OPTION CARE HEALTH INC
DCOM MODIVCARE INC
UAN DIME COMMUNITY BANCSHARES
PFBX INC.
OSCR CVR PARTNERS LP
BGS PEOPLES FINANCIAL CORP. (MISSISSIPPI)
WBD OSCAR HEALTH
TCBX B&G FOODS
BIGZ INC.
RXO_w WARNER BROS. DISCOVERY INC.
VANI THIRD COAST BANCSHARES INC
KLG_w BLACKROCK INNOVATION AND GROWTH TST
DBD RXO INC
MIO VIVANI MEDICAL INC
WPC WK KELLOGG CO
EVM DIEBOLD NIXDORF INCORPORATED
PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
W. P. CAREY AND CO. LLC
EATON VANCE INSD CALIF MUN BD FD
Lesaka gets green light to launch Employee Share Ownership Plan
Lesaka gets green light to launch Employee Share Ownership Plan JOHANNESBURG, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) (“Lesaka” or the “Company”) shareholders voted on and approved the funding and issuance of shares to the Lesaka ESOP Trust at its annual general meeting. Lincoln Mali, CEO Southern Africa, said “We are very proud of the launch of our broad-based employee share ownership plan. Lesaka has been on a far-reaching transformation journey and our employees becoming shareholders is a significant and an important milestone for us.” The...
- Jonathan Moreland
KVHI KVH INDUSTRIES INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
EXAS EXACT SCIENCES CORPORATION
CNC CENTENE CORPORATION
HLNE HAMILTON LANE INCORPORATED CLASS A
SNBR SLEEP NUMBER CORPORATION
GNL GALEY & LORD INC.
ADV ADVANTAGE SOLUTIONS INC (A)
OPCH OPTION CARE HEALTH INC
UAN CVR PARTNERS LP
OSCR OSCAR HEALTH
BGS B&G FOODS
TCBX INC.
VANI THIRD COAST BANCSHARES INC
GRNT VIVANI MEDICAL INC
SES GRANITE RIDGE RESOURCES INC
SES AI CORPORATION
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to...
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work CORAL GABLES, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it has been named on the BioSpace 2025 Best Places to Work. Catalyst is among 50 U.S. operating employers on the Best Places to Work list. The recipients are recognized as the most sought-af...
- Jonathan Moreland
RRGB RED ROBIN GOURMET BURGERS INC.
PBF PBF ENERGY INC. CLASS A
JELD JELD-WEN HOLDING INC.
SNBR SLEEP NUMBER CORPORATION
NWPP NEW PEOPLES BANKSHARES INC.
MEC MAYVILLE ENGINEERING
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
BIGZ BLACKROCK INNOVATION AND GROWTH TST
SES SES AI CORPORATION
EVM EATON VANCE INSD CALIF MUN BD FD
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial R...
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update Reports Q3 2024 Total Revenues of $128.7 Million, Representing a 25.3% YoY Increase Record Revenues Driven by Continued Organic Growth in its Rare Disease Franchise Robust Financial Performance Highlights Operational Excellence and Strong Commercial Execution FIRDAPSE® Q3 2024 Net Product Revenues of $79.3 Million, Representing a 19.7% YoY Increase AGAMREE® Q3 2024 Net Product Revenues of $15.0 Million, Demonstrating Early U.S. Launch Success FYCOMPA® Q3 2024 Net Product Revenues...
Lesaka Q1 2025 Results: Lesaka Continues Building Operational Momentum...
Lesaka Q1 2025 Results: Lesaka Continues Building Operational Momentum Achieving Revenue and Profitability Guidance JOHANNESBURG, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the first quarter of fiscal 2025 (“Q1 2025”). Q1 2025 performance: Revenue of $145.5 million (ZAR 2.6 billion) was at the mid-point of our revenue guidance and compares to $136.1 million (ZAR 2.5 billion) in Q1 2024.Operating loss of $0.05 million (ZAR 0.3 million) compares to operating income of $0.2 million (ZAR 4.2 million) in Q1 2024. The curren...
- Jonathan Moreland
ETSY ETSY INC.
AIN ALBANY INTERNATIONAL CORP. CLASS A
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
MPB MID PENN BANCORP INC.
NANX NANOPHASE TECHNOLOGIES CORP.
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
EPIX EPIX PHARMACEUTICALS
TRIN TRINITY EXPLORATION & PRODUCTION
CALC CALCIMEDICA INC.
SES SES AI CORPORATION
BTM BITCOIN DEPOT INC
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
WPC W. P. CAREY AND CO. LLC
- Jonathan Moreland
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Nuveen Floating Rate Income Fund and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 30 October 2024 in which we reassessed the appropriateness of the ratings ...
- Jonathan Moreland
- Jonathan Moreland
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Result...
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024 The Company will Host a Conference Call and Webcast on Thursday, November 7, 2024, at 8:30 AM ET CORAL GABLES, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its third quarter 2024 financial results after the market c...
- Jonathan Moreland
Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hu...
Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts CORAL GABLES, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "the Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel therapies for patients with rare diseases, today announced that it has contributed $100,000 to the American Red Cross to support ongoing relief efforts for communities impacted by Hurricane Helene. "At Catalyst, our commitment to the community is unwave...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.